ICLR vs JAZZ: Side-by-Side Comparison
Compare Icon Plc (ICLR) and Jazz Pharmaceuticals plc (JAZZ) side by side: market cap USD 13.26B vs USD 15.28B. Financials, growth and model signals on Bullrun.
| Metric | ICLR | JAZZ |
|---|---|---|
| Company | Icon Plc | Jazz Pharmaceuticals plc |
| Country / Exchange | Ireland · NASDAQ | Ireland · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Diagnostics & Research | Biotechnology |
| Market cap | USD 13.26B | USD 15.28B |
| P/E ratio | 79.7 | — |
| Dividend yield | — | — |
| Valuation model | 51.9% overvalued | — |
| Revenue (FY2025) | USD 8.25B | USD 4.27B |
| Revenue growth YoY | +0.8% | +4.9% |
| Net income | USD 229.34M | USD -356.15M |
| Gross margin | — | — |
| Diluted EPS | 2.90 | -5.84 |